Title | Journal of Experimental and Clinical Cancer Research |
Abbreviation | J. Exp. Clin. Cancer Res. |
Publication Type | Journal |
Subject Area, Categories, Scope | Cancer Research (Q1); Oncology (Q1) |
h-index | 120 |
Overall Rank/Ranking | 759 |
SCImago Journal Rank (SJR) | 2.806 |
Impact Score | 9.65 |
Publisher | BioMed Central Ltd |
Country | United Kingdom |
ISSN | 17569966, 03929078 |
Best Quartile | Q1 |
Coverage History | 1982-2023 |
Journal of Experimental and Clinical Cancer Research is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Oncology (Q1). It is published by BioMed Central Ltd. The overall rank of Journal of Experimental and Clinical Cancer Research is 759. According to SCImago Journal Rank (SJR), this journal is ranked 2.806. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 120. The best quartile for this journal is Q1.
The ISSN of Journal of Experimental and Clinical Cancer Research journal is 17569966, 03929078. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Experimental and Clinical Cancer Research is cited by a total of 9710 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal of Experimental and Clinical Cancer Research is 9.65, which is computed in 2024 as per its definition. Journal of Experimental and Clinical Cancer Research IF is increased by a factor of 0.27 and approximate percentage change is 2.88% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal of Experimental and Clinical Cancer Research is 9.65. If the same upward trend persists, Impact IF may rise in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 9.65 |
2022 | 9.38 |
2021 | 11.27 |
2020 | 9.75 |
2019 | 6.80 |
2018 | 5.38 |
2017 | 6.30 |
2016 | 5.47 |
2015 | 4.92 |
2014 | 4.92 |
Journal of Experimental and Clinical Cancer Research has an h-index of 120. It means 120 articles of this journal have more than 120 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Experimental and Clinical Cancer Research is 17569966, 03929078. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Experimental and Clinical Cancer Research is 759. According to SCImago Journal Rank (SJR), this journal is ranked 2.806. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 2.806 |
2022 | 2.413 |
2021 | 2.350 |
2020 | 2.752 |
2019 | 2.127 |
2018 | 1.761 |
2017 | 2.000 |
2016 | 1.612 |
2015 | 1.639 |
2014 | 1.653 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 759 |
2022 | 952 |
2021 | 947 |
2020 | 749 |
2019 | 1179 |
2018 | 1704 |
2017 | 1381 |
2016 | 2081 |
2015 | 2051 |
2014 | 1956 |
Journal of Experimental and Clinical Cancer Research is published by BioMed Central Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1982-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Experimental and Clinical Cancer Research is J. Exp. Clin. Cancer Res.. This abbreviation ('J. Exp. Clin. Cancer Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Experimental and Clinical Cancer Research latest impact IF is 9.65. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 11.27 (2021) and 4.92 (2015), respectively, in the last 10 years. Moreover, its average IS is 7.38 in the previous 10 years.
The Journal of Experimental and Clinical Cancer Research has an SJR (SCImago Journal Rank) of 2.806, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.806 in 2023 and the lowest being 1.612 in 2016. Furthermore, the average SJR of the Journal of Experimental and Clinical Cancer Research over the previous 10-year period stands at 7.38.
The latest h-index of the Journal of Experimental and Clinical Cancer Research is 120.
The Journal of Experimental and Clinical Cancer Research is published by the BioMed Central Ltd, with its country of publication being the United Kingdom.
The Journal of Experimental and Clinical Cancer Research is currently ranked 759 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 749 in 2020 and its lowest position of 2081 in 2016.
The standard ISO4 abbreviation for the Journal of Experimental and Clinical Cancer Research is J. Exp. Clin. Cancer Res..
Journal of Experimental and Clinical Cancer Research is classified as a journal that the BioMed Central Ltd publishes.
The Journal of Experimental and Clinical Cancer Research encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Experimental and Clinical Cancer Research is assigned the following International Standard Serial Numbers (ISSN): 17569966, 03929078.
The best quartile for the Journal of Experimental and Clinical Cancer Research is Q1 (2023).
The Journal of Experimental and Clinical Cancer Research coverage history can be summarized as follows: 1982-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
Journal of Sociolinguistics | journal | 3273 | Wiley-Blackwell Publishing Ltd | 64 | 1.85 |
Syntax | journal | 3731 | Wiley-Blackwell Publishing Ltd | 33 | 0.93 |
Studies in Continuing Education | journal | 7550 | Routledge | 40 | 3.04 |
Archives of the Balkan Medical Union | journal | 23592 | Balkan Medical Union | 12 | 0.21 |
Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
Canadian Journal of Mathematics | journal | 9072 | Canadian Mathematical Society | 45 | 0.78 |
European Journal of Wildlife Research | journal | 9693 | Springer Verlag | 59 | 1.76 |
Psycho-Oncologie | journal | 25301 | Tech Science Press | 11 | 0.10 |
Metascience | journal | 24313 | Springer Nature | 3 | 0.00 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 9.65 |
2022 | 9.38 |
2021 | 11.27 |
2020 | 9.75 |
2019 | 6.80 |
2018 | 5.38 |
2017 | 6.30 |
2016 | 5.47 |
2015 | 4.92 |
2014 | 4.92 |